Carmen Mrestani‐Klaus

The N-terminal Structure of HIV-1 Tat Is Required for Suppression of CD26-dependent T Cell Growth

Sabine Wrenger, Torsten Hoffmann, Jürgen Faust et al. · Journal of Biological Chemistry · 1997 · 61 citations · Full text

Different modes of dipeptidyl peptidase IV (CD26) inhibition by oligopeptides derived from the N‐terminus of HIV‐1 Tat indicate at least two inhibitor binding sites

Susan Lorey, Angela Stöckel‐Maschek, Jürgen Faust et al. · European Journal of Biochemistry · 2003 · 56 citations

Cyclic .beta.-Casomorphin Analogs with Mixed .mu. Agonist/.delta. Antagonist Properties: Synthesis, Pharmacological Characterization, and Conformational Aspects

Ralf Schmidt, D. Vogel, Carmen Mrestani‐Klaus et al. · Journal of Medicinal Chemistry · 1994 · 50 citations · Full text

Thioxo amino acid pyrrolidides and thiazolidides: new inhibitors of proline specific peptidases

Angela Stöckel‐Maschek, Carmen Mrestani‐Klaus, Beate Stiebitz et al. · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · 2000 · 40 citations

Proline Specific Peptidases, Biochemistry, Medicine +10

Down-regulation of T Cell Activation following Inhibition of Dipeptidyl Peptidase IV/CD26 by the N-terminal Part of the Thromboxane A2 Receptor

Sabine Wrenger, Jürgen Faust, Carmen Mrestani‐Klaus et al. · Journal of Biological Chemistry · 2000 · 37 citations · Full text